Judges Scientific (JDG) Share Price, News & Analysis

Company Overview

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 23 businesses acquired since 2005. The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export. The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins. Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends. For further information, please visit www.judges.uk.com

Key Stats

• Today's Range: 6,020 to 6,180
• 50-Day Range: 5,960 to 8,110
• 52-Week Range: 5,900 to £122.50
• Volume: 25,123 shs
• Average Volume: 21,525 shs
• Market Capitalization: £404.42 million
• P/E Ratio: 27.08
• Dividend Yield: 1.59%
• Price Target: £114.15
• Consensus Rating: Buy

Judges Scientific Stock Analysis - MarketRank™

Judges Scientific scored higher than 64% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Judges Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Judges Scientific has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Judges Scientific is 27.08, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.96.

Price to Earnings Ratio vs. Sector

The P/E ratio of Judges Scientific is 27.08, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 43.38.

Price to Earnings Growth Ratio

Judges Scientific has a PEG Ratio of 0.56. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Judges Scientific has a P/B Ratio of 4.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for JDG.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Judges Scientific pays a meaningful dividend of 1.31%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Judges Scientific does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Judges Scientific is 43.09%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for JDG.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Judges Scientific this week, compared to 1 article on an average week.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Judges Scientific insiders have bought more of their company's stock than they have sold. Specifically, they have bought £38,493.92 in company stock and sold GBX 0 in company stock.

Percentage Held by Insiders

18.75% of the stock of Judges Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

51.59% of the stock of Judges Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

JDG Stock Analysis - Frequently Asked Questions

How have JDG shares performed this year?

Judges Scientific's stock was trading at GBX 8,499 on January 1st, 2025. Since then, JDG shares have decreased by 27.5% and is now trading at GBX 6,160.
View the best growth stocks for 2025 here.

How were Judges Scientific's earnings last quarter?

Judges Scientific plc (LON:JDG) issued its earnings results on Wednesday, March, 19th. The company reported $283.40 earnings per share for the quarter. Judges Scientific had a net margin of 10.99% and a trailing twelve-month return on equity of 17.56%.

How do I buy shares of Judges Scientific?

Shares of JDG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Judges Scientific own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Judges Scientific investors own include Coats Group (COA), Taboola.com (TBLA), Barclays (BARC), BP (BP), Greencore Group (GNC), Intel (INTC) and JD Sports Fashion (JD).

Company Calendar

• Last Earnings: 3/19/2025
• Today: 5/05/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Computer and Technology
• Industry: Scientific & Technical Instruments
• Sub-Industry: N/A
• Current Symbol: LON:JDG
• CIK: N/A
• Web: www.judges.uk.com
• Phone: +44-20-38296970
• Fax: N/A
• Employees: 682
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: £114.15
• High Stock Price Target: £122.30
• Low Stock Price Target: £106
• Potential Upside/Downside: +85.3%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX 227.46
• Trailing P/E Ratio: 27.08
• Forward P/E Ratio: 15.30
• P/E Growth: 0.56
• Net Income: £14.75 million
• Net Margins: 10.99%
• Pretax Margin: N/A
• Return on Equity: 17.56%
• Return on Assets: 7.35%

Debt

• Debt-to-Equity Ratio: 70.79
• Current Ratio: 1.97
• Quick Ratio: 0.65

Sales & Book Value

• Annual Sales: £134.28 million
• Price / Sales: 3.01
• Cash Flow: GBX 422.93 per share
• Price / Cash Flow: 14.57
• Book Value: GBX 1,318.28 per share
• Price / Book: 4.67

Miscellaneous

• Outstanding Shares: 6,565,179
• Free Float: N/A
• Market Cap: £404.42 million
• Optionable: Not Optionable
• Beta: 0.83